Michael Carulli
Chief Financial Officer at PMV Pharmaceuticals, Inc. (PMVP) since January 2024
Michael Carulli has filed 7 insider reports with the SEC since January 2024, as chief Financial Officer at PMV Pharmaceuticals, Inc. (PMVP). Michael Carulli made no open-market purchases or sales in the last 12 months. The latest filing, on March 9, 2026, reports grant or award at PMV Pharmaceuticals, Inc. (PMVP).
- Filings
- 7
- Companies
- 1
- Bought on market
- None
- Sold on market
- $34.4K
Companies where Michael Carulli is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince January 2024 | 73,848 | $34.4K | $1.31 | Mar 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 5, 2026PMVPSEC Form 4 filed by Chief Financial Officer Carulli MichaelForm 4Grant or award
- Jul 1, 2025-$30.1KPMVPChief Financial Officer Carulli Michael sold $30,077 worth of shares (28,249 units at $1.06), decreasing direct ownership by 32% to 60,146 unitsForm 4Open-market sale
- Mar 3, 2025PMVPSEC Form 4 filed by Chief Financial Officer Carulli MichaelForm 4Grant or award
- Aug 13, 2024PMVPSEC Form 4 filed by Chief Financial Officer Carulli MichaelForm 4Grant or awardSale back to the company
- Sep 11, 2024-$4,347PMVPChief Financial Officer Carulli Michael sold $4,347 worth of shares (2,891 units at $1.50), decreasing direct ownership by 3% to 88,395 unitsForm 4Open-market sale
- Jan 18, 2024PMVPCarulli Michael was granted 82,220 shares, increasing direct ownership by 907% to 91,286 unitsForm 4Grant or award
- Jan 5, 2024PMVPNew insider Carulli Michael claimed ownership of 9,066 sharesForm 3New insider
Compare Michael Carulli with
- Michael Carulli vs Laurie Stelzer1 shared
- Michael Carulli vs Arnold J Levine1 shared
- Michael Carulli vs Carol Giltner Gallagher1 shared
- Michael Carulli vs Kirsten Flowers1 shared
- Michael Carulli vs Charles M Baum1 shared
- Michael Carulli vs Robert Ticktin1 shared
Other insiders at the same companies
- Laurie StelzerPMVP
- Arnold J LevinePMVP
- Carol Giltner GallagherPMVP
- Kirsten FlowersPMVP
- Charles M BaumPMVP
- Robert TicktinPMVP
- Deepika JalotaPMVP
- David Henry MackPMVP
- Orbimed Advisors LLCPMVP
- Richard A. HeymanPMVP
Questions about Michael Carulli
- What is Michael Carulli's role at PMV Pharmaceuticals, Inc.?
- Michael Carulli reports to the SEC as chief Financial Officer at PMV Pharmaceuticals, Inc. (PMVP), according to the latest filing on March 9, 2026.
- How many shares does Michael Carulli own?
- After the latest filing that states it, Michael Carulli directly owned 73,848 shares of PMV Pharmaceuticals, Inc. (PMVP). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Carulli bought or sold stock recently?
- The most recent open-market sale was on July 1, 2025: sold 28,249 shares of PMV Pharmaceuticals, Inc. (PMVP) for $30.1K at an average of $1.06.
- How do I get alerts when Michael Carulli files?
- Follow Michael Carulli on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Carulli (SEC CIK 0002006668). Totals count each trade once, skipping amendments whose original is on file, from Jan 11, 2024 on. View on SEC EDGAR · Get this as JSON